elagolix 300 MG Oral Capsule

RxCUI: 2371766
RxNorm name: elagolix 300 MG Oral Capsule
Display name: elagolix 300 MG Oral Capsule
Full name: elagolix 300 MG Oral Capsule
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Oriahnn	ELAGOLIX AND ESTRADIOL AND NORETHISTERONE	AbbVie Inc.	99f6eee7-7e52-6999-7eb8-488d06dd1710	2025-12-19	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2371766

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
99f6eee7-7e52-6999-7eb8-488d06dd1710	elagolix 300 MG Oral Capsule	SCD	41	These highlights do not include all the information needed to use ORIAHNN safely and effectively. See full prescribing information for ORIAHNN. ORIAHNN ® (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules), co-packaged for oral use Initial U.S. Approval: 2020	20251219
99f6eee7-7e52-6999-7eb8-488d06dd1710	elagolix 300 MG Oral Capsule	PSN	41	These highlights do not include all the information needed to use ORIAHNN safely and effectively. See full prescribing information for ORIAHNN. ORIAHNN ® (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules), co-packaged for oral use Initial U.S. Approval: 2020	20251219